My watch list
my.bionity.com  
Login  

Lexicon Pharmaceuticals



Lexicon Pharmaceuticals
Public (NASDAQ: LXRX)
FoundedThe Woodlands, TX, 1995
HeadquartersThe Woodlands, Princeton, New Jersey ,
USA
Key peopleArthur T. Sands, CEO
Alan J. Main, VP
IndustryHealth Care
Employees600 (2007)
SloganDiscovering Breakthrough Treatments For Human Disease
Websitewww.lexpharma.com

Lexicon Genetics is a medium sized biopharmaceuticals company that started operation in 1995 in The Woodlands, Texas. Lexicon genetics changed it's name in 2007 to Lexicon Pharmaceuticals (Nasdaq LXRX) to showcase itself as a full blown biotech company. The company started during the biotech bubble days as a small startup, based on its patented mouse knockout technology.In June, 2003 Lexicon Genetics purchased a privately owned small chemical library synthesis company, Coelacanth Corporation in Princeton, New Jersey[1] and renamed the newly acquired company as Lexicon Pharmaceuticals Inc. Since 2001, Lexicon's drug discovery program harmoniously operated between biology division (situated in The Woodlands) and medicinal chemistry (in Princeton).

Additional recommended knowledge

References

  1. ^ United States Securities and Exchange Commission


 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Lexicon_Pharmaceuticals". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE